HT941024N0110 SOLE SOURCE JA_Redacted.pdf
PDF 304 KB Posted
- Attached to
- Intercept Platelet Processing Sets
- Solicitation number
- HT941024P0214
- Issued by
-
Defense Health Agency
About this file
This document is a Sole Source Justification for the procurement of Intercept Platelet Processing Sets for the Naval Medicine Readiness and Training Command - Naval Medical Center San Diego (NMRTC-NMCSD). The sole source award will establish a Base plus 2 One-Year Option purchase order with Cerus Corporation (UEI # KJJQRRLY2FL5, CAGE # 1PVJ6) as the only manufacturer capable of providing the compatible equipment required by the facility. Market research determined Cerus Corporation does not have any authorized distributors, and no other vendors were identified as capable of meeting the government's minimum requirements. The Contracting Officer will determine the proposed price is fair and reasonable based on historical pricing data and comparison to the independent government estimate. The acquisition supports the laboratory's need for dependable and reliable in-vitro diagnostic equipment for patient care. The contract was awarded on 2024-09-03 for $232,128.00.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| HT941024P0214 RELEASED.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DHA PGI 213.5, Attachment 1 (06-21-2018) and previous acquisition history, it has been determined that the only manufacturer capable of meeting the Government’s minimum requirements is Cerus Corporation. (UEI # KJJQRRLY2FL5, CAGE # 1PVJ6). The Naval Medicine Readiness and Training Command requires a laboratory that will provide a continuous support of In Vitro Diagnostic Equipment that is dependable and reliable for individual diagnosis requirements for patients utilizing the medical center.
6. Efforts to Obtain Competition:
A Notice of Intent to Sole Source was posted from 25 July to 9 August 2024 to SAM.gov to ensure there are no other capable vendors. Cerus Corporation. (UEI # KJJQRRLY2FL5, CAGE # 1PVJ6) is the only option due to nature of the compatibility and need. No additional vendors were identified because of this posting. Furthermore, Cerus Corporation does not have any authorized distributors for their products.
7. Determination that Anticipated Cost to the Government will be Fair and Reasonable:
In accordance with the basis for award procedures at FAR 13.106-3, the Contracting Officer will utilize a comparison of the proposed price with prices found reasonable on previous purchases and a comparison of the price to the independent Government estimate provided by the requiring activity to determine the vendor's quoted price fair and reasonable. Additionally, the Government has historical pricing information from similar contracts that provided similar services. The cumulative data available to the Contracting Officer provides for the ability to determine a fair and reasonable price in accordance with FAR 13.106-3(a)(2).
8. Market Research:
Market research was conducted by technical experts in August 2024. Additional market research was conducted in July/August 2024 by the Contract Specialist (CS) to verify technical expert finding. This research consisted of reviews of similar previous procurements, using search engines to find open market contractors, reviewing mandatory sources, and posting a Notice of Intent to Sole Source. Search engines utilized include SAM.gov, FPDS-NG, Federal Prison Industries (FPI), Ability One, ECAT-DLA, and GSA Advantage to identify potential sources that can meet the Government's requirements. The objective of this sole source award is to establish a Base plus 2 One-Year Option purchase order to procure Intercept Platelet Processing Sets for use in the Laboratory at Naval Medicine Readiness and Training Command - Naval Medical Center San Diego (NMRTC-NMCSD). Market research has determined that Cerus Corporation is the only manufacture that can provide Intercept Platelet Processing Sets which are compatible with existing Cerus equipment currently used by the facility. The Notice of Intent to Sole Source HT941024N0110 was posted on the System for Award Management website (SAM.gov) from 25 July 2024 to 9 August 2024 in accordance with FAR Subpart 5.2. Market research has determined this purchase order shall be established with Cerus Corporation. (UEI #
KJJQRRLY2FL5, CAGE # 1PVJ6).
9. Other Facts:
A search for the same supplies in FPDS-NG proved that Cerus Corporation (UEI # KJJQRRLY2FL5, CAGE # 1PVJ6) is the only manufacturer that can fabricate the Intercept Platelet Processing Sets compatible with currently used equipment.
DHA PGI 213.5, Attachment 1 (06-21-2018)
10. Interested Sources:
The only interested source was Cerus Corporation. (UEI # KJJQRRLY2FL5, CAGE # 1PVJ6) which is the only manufacturer that can fabricate the Intercept Platelet Processing Sets. Market research and the posting of a Notice of Intent to Sole Source did not identify any additional interested parties.
11. Actions to overcome barriers:
The Naval Medicine Readiness and Training Command - Naval Medical Center San Diego (NMRTC-NMCSD) will continue to survey and engage the market of any potential vendors that can provide Intercept Platelet Processing Sets and will consider competing future requirements if there are other vendors capable of meeting the Government’s requirements.
File details come from the government source that posted it. Updated .